Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giacomo Aimar
Observed name:
G. Aimar
Institution:
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
A. O. Ordine Mauriziano di Torino,
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo,
Candiolo Cancer Institute,
University of Turin
show all 6
ORCID:
0000-0003-3950-1374
Observed ORCID:
0000-0003-3950-1374
OpenAlex ID:
A5028953415
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study
2022
·
Giulia Mentrasti
, Luca Cantini
, et al.
·
The Oncologist
·
33
PDF
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study
2023
·
Laura Marandino
, Federica Trastu
, et al.
·
BMJ Oncology
·
32
PDF
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study
2023
·
Alessandro Rossi
, Giacomo Aimar
, et al.
·
European Journal of Cancer
·
31
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)
2022
·
Pasquale Lombardi
, Giacomo Aimar
, et al.
·
Oncology Reports
·
19
PDF
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients
2021
·
Andrea Casadei-Gardini
, Roberto Filippi
, et al.
·
Oncology
·
19
Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?
2019
·
Elisabetta Fenocchio
, Roberto Filippi
, et al.
·
Cancers
·
19
PDF
Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study
2021
·
Alessandro Parisi
, Giampiero Porzio
, et al.
·
Clinical Colorectal Cancer
·
12
Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives
2019
·
Roberto Filippi
, Pasquale Lombardi
, et al.
·
Expert Opinion on Pharmacotherapy
·
11
Patients with cancer and hospital admissions: disease trajectory and strategic choices
2023
·
Gianmauro Numico
, Rachele Ferrua
, et al.
·
BMJ Supportive & Palliative Care
·
6
A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step?
2021
·
Giacomo Aimar
, Chiara Paratore
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
6
PDF
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study
2021
·
Alessandro Parisi
, Alessio Cortellini
, et al.
·
Frontiers in Oncology
·
6
PDF
Advanced hepatocellular carcinoma: Impact of systemic treatments on health‐related quality of life and patient‐reported outcomes
2022
·
Giacomo Aimar
, Donatella Marino
, et al.
·
Liver Cancer International
·
5
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
2021
·
Paolo Antonetti
, Maria Concetta Fargnoli
, et al.
·
Supportive Care in Cancer
·
4
LDH as prognostic factor in second line treatment for advanced gastric cancer: The LINE study.
2021
·
Anna Michelotti
, Marco de Scordilli
, et al.
·
Journal of Clinical Oncology
·
4
Impact of Different Dosing Strategies of Nivolumab in Patients With Solid Tumors: Italian Single Center Analysis
2021
·
T. Gamba
, A. Caglio
, et al.
·
Annals of Research in Oncology
·
2
PDF
448P Predictive factor of cardiotoxicity in fluoropyrimidine-treated colorectal cancer patients: Interim analysis of the prospective observational CHECKPOINT trial
2020
·
G. Aimar
, P. Lombardi
, et al.
·
Annals of Oncology
·
2
PDF
Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: Preliminary data from the prospective observational CHECKPOINT trial (NCT02665312)
2019
·
P. Lombardi
, G. Aimar
, et al.
·
Annals of Oncology
·
2
PDF
569eP Gender equity in lung cancer clinical trials: The ENGAGE study
2026
·
A. Mogavero
, C. Paratore
, et al.
·
ESMO Open
PDF
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation
2025
·
Gianmauro Numico
, Elena Fea
, et al.
·
Tumori Journal
1715P Analysis of the adequacy of control arms in oncology randomized clinical trials published between 2017 and 2021: A meta-research study
2023
·
A. Rossi
, G. Aimar
, et al.
·
Annals of Oncology
PDF
1626P Time trends (2012-2016 vs 2017-2021) in health-related quality of life (QoL) assessment and reporting in oncology: A systematic review of randomized phase III trials
2022
·
L. Marandino
, F. Trastu
, et al.
·
Annals of Oncology
1616P Drop in early-stage colorectal cancer diagnoses after COVID-19: Preliminary report from the COVID-DELAY study
2021
·
G. Mentrasti
, V. Cognigni
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
22
Citation count:
213
H-index:
8
I10-index:
8
Year
Topic
Type